Cargando…
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient
We present an exceptional case of a patient with high-grade serous ovarian cancer, treated with multiple chemotherapy regimens, who exhibited regression of some metastatic lesions with concomitant progression of other lesions during a treatment-free period. Using immunogenomic approaches, we found t...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589211/ https://www.ncbi.nlm.nih.gov/pubmed/28841418 http://dx.doi.org/10.1016/j.cell.2017.07.025 |
_version_ | 1783262289653137408 |
---|---|
author | Jiménez-Sánchez, Alejandro Memon, Danish Pourpe, Stephane Veeraraghavan, Harini Li, Yanyun Vargas, Hebert Alberto Gill, Michael B. Park, Kay J. Zivanovic, Oliver Konner, Jason Ricca, Jacob Zamarin, Dmitriy Walther, Tyler Aghajanian, Carol Wolchok, Jedd D. Sala, Evis Merghoub, Taha Snyder, Alexandra Miller, Martin L. |
author_facet | Jiménez-Sánchez, Alejandro Memon, Danish Pourpe, Stephane Veeraraghavan, Harini Li, Yanyun Vargas, Hebert Alberto Gill, Michael B. Park, Kay J. Zivanovic, Oliver Konner, Jason Ricca, Jacob Zamarin, Dmitriy Walther, Tyler Aghajanian, Carol Wolchok, Jedd D. Sala, Evis Merghoub, Taha Snyder, Alexandra Miller, Martin L. |
author_sort | Jiménez-Sánchez, Alejandro |
collection | PubMed |
description | We present an exceptional case of a patient with high-grade serous ovarian cancer, treated with multiple chemotherapy regimens, who exhibited regression of some metastatic lesions with concomitant progression of other lesions during a treatment-free period. Using immunogenomic approaches, we found that progressing metastases were characterized by immune cell exclusion, whereas regressing and stable metastases were infiltrated by CD8(+) and CD4(+) T cells and exhibited oligoclonal expansion of specific T cell subsets. We also detected CD8(+) T cell reactivity against predicted neoepitopes after isolation of cells from a blood sample taken almost 3 years after the tumors were resected. These findings suggest that multiple distinct tumor immune microenvironments co-exist within a single individual and may explain in part the heterogeneous fates of metastatic lesions often observed in the clinic post-therapy. VIDEO ABSTRACT: |
format | Online Article Text |
id | pubmed-5589211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Cell Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-55892112017-09-15 Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient Jiménez-Sánchez, Alejandro Memon, Danish Pourpe, Stephane Veeraraghavan, Harini Li, Yanyun Vargas, Hebert Alberto Gill, Michael B. Park, Kay J. Zivanovic, Oliver Konner, Jason Ricca, Jacob Zamarin, Dmitriy Walther, Tyler Aghajanian, Carol Wolchok, Jedd D. Sala, Evis Merghoub, Taha Snyder, Alexandra Miller, Martin L. Cell Article We present an exceptional case of a patient with high-grade serous ovarian cancer, treated with multiple chemotherapy regimens, who exhibited regression of some metastatic lesions with concomitant progression of other lesions during a treatment-free period. Using immunogenomic approaches, we found that progressing metastases were characterized by immune cell exclusion, whereas regressing and stable metastases were infiltrated by CD8(+) and CD4(+) T cells and exhibited oligoclonal expansion of specific T cell subsets. We also detected CD8(+) T cell reactivity against predicted neoepitopes after isolation of cells from a blood sample taken almost 3 years after the tumors were resected. These findings suggest that multiple distinct tumor immune microenvironments co-exist within a single individual and may explain in part the heterogeneous fates of metastatic lesions often observed in the clinic post-therapy. VIDEO ABSTRACT: Cell Press 2017-08-24 /pmc/articles/PMC5589211/ /pubmed/28841418 http://dx.doi.org/10.1016/j.cell.2017.07.025 Text en © 2017 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jiménez-Sánchez, Alejandro Memon, Danish Pourpe, Stephane Veeraraghavan, Harini Li, Yanyun Vargas, Hebert Alberto Gill, Michael B. Park, Kay J. Zivanovic, Oliver Konner, Jason Ricca, Jacob Zamarin, Dmitriy Walther, Tyler Aghajanian, Carol Wolchok, Jedd D. Sala, Evis Merghoub, Taha Snyder, Alexandra Miller, Martin L. Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient |
title | Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient |
title_full | Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient |
title_fullStr | Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient |
title_full_unstemmed | Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient |
title_short | Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient |
title_sort | heterogeneous tumor-immune microenvironments among differentially growing metastases in an ovarian cancer patient |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589211/ https://www.ncbi.nlm.nih.gov/pubmed/28841418 http://dx.doi.org/10.1016/j.cell.2017.07.025 |
work_keys_str_mv | AT jimenezsanchezalejandro heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT memondanish heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT pourpestephane heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT veeraraghavanharini heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT liyanyun heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT vargashebertalberto heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT gillmichaelb heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT parkkayj heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT zivanovicoliver heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT konnerjason heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT riccajacob heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT zamarindmitriy heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT walthertyler heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT aghajaniancarol heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT wolchokjeddd heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT salaevis heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT merghoubtaha heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT snyderalexandra heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient AT millermartinl heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient |